NEXAPH

NEXAPH lists 60 research peptides on Peptides.SO, most of them ten-vial kits, at a $235.50 median list price, the sixth-highest of 118 catalogues. Every one of the 60 listings carried a sale price at the last feed pass, which puts NEXAPH among 8 suppliers on the platform with their whole catalogue discounted, and 49 of 60 were in stock.

Catalogue shape from platform data: 25 listings state a ten-vial kit in the name. Those include BPC-157 10mg ($178, on sale at $152), Ipamorelin 10mg ($228, sale $178), KPV 10mg ($170, sale $143), TB4 10mg ($298, sale $251), TB-500 fragment 17-23 10mg ($188, sale $161), PDA 10mg ($158, sale $134), PT-141 10mg ($188, sale $168), VIP 10mg at two prices, GHK-Cu lyophilised ($148, sale $125), a Glow Blend at two prices ($418 and $530), buffered NAD+ 250mg at two prices and the supplier's own NXP-2P line at six price points from $170 to $575 plus a pre-order NXP-3P 48mg line at five price points up to $1,000. The remaining 35 entries do not state a count and include Selank and Semax at $178 and $278 each, Tesamorelin at $368 and $378, BPC-157 at $228 and $368, ARA-290 ($288), LL-37 ($418), Thymosin alpha-1 at $75 and $338, Melanotan I 10mg ($228), Epitalon ($168), Cagrilintide 10mg at $224 and $388, Survodutide 10mg ($378), CJC-1295 no DAC 5mg ($198), a CJC/Ipamorelin blend ($258), Sermorelin ($198), 5-Amino-1MQ ($238), AOD-9604 ($148), MOTS-c ($248), SNAP-8 ($130), a GHK-Cu/KPV beauty blend ($375), Klow 80mg ($530), AHK-Cu topical ampoules at two prices, Dihexa tablets ($350), DSIP 5mg ($65), LIPO-C with B12 ($224) and three branded bottle and vial openers between $12 and $20.

Against the rest of the platform, none of NEXAPH's 27 comparable products is below the single-vial median and 26 are above it, typically by three to five times: Selank $178 and $278 against a $49.25 median across 90 suppliers, Semax against $55 (92 suppliers), Tesamorelin $368 and $378 against $80.38 (93 suppliers), BPC-157 $228 and $368 against $90 (91 suppliers), LL-37 $418 against $79.50, Melanotan I $228 against $43.50, Cagrilintide $224 and $388 against $102.50, Sermorelin $198 against $60 and MOTS-c $248 against $69.95. The one exception is the $75 Thymosin alpha-1 listing, which sits on the $74.50 median and reads like a single vial. Multiples of that size on entries that do not state a count are consistent with kit pricing under a single-vial product name, so confirm the vial count with the supplier before treating any of these as a per-vial price.

Verification status on Peptides.SO: NEXAPH is not platform-verified, has a testing score of 0 out of 7 criteria and no Certificate of Analysis on file, and it has no platform reviews yet. No payment-method data has been captured from its storefront. Because no active supplier currently has a testing criterion or COA recorded on the platform and only 3 of 169 are verified, this is the shared baseline; request batch-specific analytical documentation before ordering. Fifty-eight of the 60 listings were refreshed by the September 2026 feed.

Common questions. Is NEXAPH expensive? At face value its $235.50 median is the sixth-highest on the platform, but 25 listings are explicitly ten-vial kits and most of the rest are priced like kits, so the per-vial figure is roughly a tenth of what is shown. Which listing is closest to single-vial pricing? Thymosin alpha-1 at $75. Is everything on sale? Yes at the last pass, with markdowns from about 10 to 40 percent on list.

Peptides sold through suppliers on Peptides.SO are for in-vitro laboratory research only. They are not approved or intended for human or animal use, clinical administration or consumption.